Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chronomodulated Irinotecan + 5-FU/LV + Oxaliplatin in mCRC
NCT00039208Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Feb 2002
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of irinotecan in metastatic colorectal cancer (mCRC), sponsored by European Organisation for Research and Treatment of Cancer. Started Feb 2002; status: completed.
02
Drugs
irinotecan
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT00039208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00039208.